Incyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. 

CEO
William J. Meury
CEOWilliam J. Meury
Employees
2,617
Employees2,617
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
1991
Founded1991
Employees
2,617
Employees2,617

INCY Key Statistics

Market cap
17.19B
Market cap17.19B
Price-Earnings ratio
19.85
Price-Earnings ratio19.85
Dividend yield
Dividend yield
Average volume
1.80M
Average volume1.80M
High today
$88.21
High today$88.21
Low today
$87.25
Low today$87.25
Open price
$87.40
Open price$87.40
Volume
1.48M
Volume1.48M
52 Week high
$92.86
52 Week high$92.86
52 Week low
$53.56
52 Week low$53.56

INCY News

TipRanks 3d
Incyte’s Clinical Developments Show Promise Amidst Competitive Challenges and Uncertain Revenue Potential

J.P. Morgan analyst Jessica Fye has maintained their neutral stance on INCY stock, giving a Hold rating today. Elevate Your Investing Strategy: Take advantage o...

TipRanks 3d
Cautious Optimism for Incyte’s Early-Stage Cancer Therapies: Hold Rating Pending Further Data

In a report released today, Judah Frommer from Morgan Stanley maintained a Hold rating on Incyte, with a price target of $79.00. Elevate Your Investing Strategy...

TipRanks 3d
Incyte announces clinical data on TGFbetaR2PD-1 bispecific antibody

Incyte (INCY) announced the first clinical data evaluating its TGFbetaR2PD-1 bispecific antibody for patients with microsatellite stable, MSS, colorectal cancer...

Analyst ratings

57%

of 28 ratings
Buy
32.1%
Hold
57.1%
Sell
10.7%

More INCY News

TipRanks 5d
Bollinger, Credo, Ambarella, Cipher, Incyte: Insider Moves Unveiled!

Insiders have been trading these 5 stocks: ((BINI)), ((CRDO)), ((AMBA)), ((CIFR)) and ((INCY)). Here is a breakdown of their recent trades and their value. Elev...

Simply Wall St 7d
A Look at Incyte’s Valuation Following Positive Early Data for New Cancer Therapies

Incyte (INCY) recently shared promising results from early-stage clinical trials of two potential therapies for advanced cancers, including colorectal and pancr...

A Look at Incyte’s Valuation Following Positive Early Data for New Cancer Therapies

People also own

Based on the portfolios of people who own INCY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.